Bionexus Gene Lab Corp · NASDAQ:BGLC

Tan Lee Su-Leng reported a 11.50% stake in Bionexus Gene Lab Corp (Schedule 13D)

Event Aug 13, 2026 · Filed Aug 14, 2026

Tan Lee Su-Leng reported a 11.50% stake in Bionexus Gene Lab Corp, 338,709 shares, with active intent on Aug 13, 2026. Filed Aug 14, 2026 (Schedule 13D).

Stake
11.50%
Shares
338,709
Intent
Active
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Tan Lee Su-Leng11.50%338,709

Source

View original at SEC

Related